Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA To Issue Five Guidances On Adaptive Clinical Trial Design

This article was originally published in The Pink Sheet Daily

Executive Summary

The agency will issue a total of five guidance documents regarding adaptive clinical trials, the first of which will examine using multiple endpoints in the same trial.

You may also be interested in...



Slow Down The Adaptive Trials Train, FDA Says

More definitions are needed to ensure that adaptive clinical trials are "not a fad but an innovation," agency tells PhRMA-sponsored workshop.

Slow Down The Adaptive Trials Train, FDA Says

More definitions are needed to ensure that adaptive clinical trials are "not a fad but an innovation," agency tells PhRMA-sponsored workshop.

Adaptive Clinical Trials Should Still Be Designed “Conservatively,” Integra Consultant Says

Assuming a study will need to be large could lead to cost-savings if stopped early, while starting with a small design could result in problems if expansion is needed.

Related Content

Topics

UsernamePublicRestriction

Register

IV001392

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel